BioNTech SE
BNTX
$96.37
-$0.36-0.37%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.78B | 295.99M | 192.37M | 1.27B | 1.37B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.78B | 295.99M | 192.37M | 1.27B | 1.37B |
| Cost of Revenue | 173.38M | 86.71M | 88.19M | 259.56M | 196.68M |
| Gross Profit | 1.60B | 209.28M | 104.18M | 1.01B | 1.17B |
| SG&A Expenses | 173.61M | 155.94M | 126.91M | 140.81M | 165.46M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 807.04M | -28.83M | -55.56M | 47.01M | 378.41M |
| Total Operating Expenses | 1.81B | 791.61M | 712.65M | 1.10B | 1.35B |
| Operating Income | -38.58M | -495.62M | -520.28M | 168.96M | 22.98M |
| Income Before Tax | 28.88M | -457.04M | -468.71M | 321.07M | 174.47M |
| Income Tax Expenses | 62.43M | -18.27M | -31.15M | 44.45M | -43.32M |
| Earnings from Continuing Operations | -33.55M | -438.76M | -437.57M | 276.62M | 217.79M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -33.55M | -438.76M | -437.57M | 276.62M | 217.79M |
| EBIT | -38.58M | -495.62M | -520.28M | 168.96M | 22.98M |
| EBITDA | 106.62M | -437.74M | -475.24M | 296.66M | 71.79M |
| EPS Basic | -0.14 | -1.82 | -1.82 | 1.15 | 0.90 |
| Normalized Basic EPS | 0.12 | -1.11 | -1.15 | 0.92 | 0.57 |
| EPS Diluted | -0.14 | -1.82 | -1.82 | 1.15 | 0.89 |
| Normalized Diluted EPS | 0.12 | -1.11 | -1.15 | 0.92 | 0.56 |
| Average Basic Shares Outstanding | 239.17M | 241.63M | 240.35M | 240.28M | 241.59M |
| Average Diluted Shares Outstanding | 239.17M | 241.63M | 240.35M | 240.28M | 244.57M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |